lubiprostone has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Esumi, S; Kajizono, M; Kitamura, Y; Sada, H; Sendo, T; Ushio, S | 1 |
| Kawamoto, R; Kikuchi, A; Kumagi, T; Ninomiya, D | 1 |
| Thomas, J | 1 |
1 review(s) available for lubiprostone and Benign Neoplasms
| Article | Year |
|---|---|
Cancer-related constipation.
Topics: Alprostadil; Constipation; Fatty Acids; Gastrointestinal Agents; Humans; Indoles; Lubiprostone; Naltrexone; Narcotic Antagonists; Neoplasms; Piperidines; Quaternary Ammonium Compounds; Serotonin Receptor Agonists | 2007 |
2 other study(ies) available for lubiprostone and Benign Neoplasms
| Article | Year |
|---|---|
The Efficacy and Safety of Lubiprostone for Constipation in Cancer Patients Compared with Non-cancer Patients: A Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Constipation; Defecation; Diarrhea; Female; Humans; Incidence; Lubiprostone; Male; Middle Aged; Nausea; Neoplasms; Retrospective Studies; Treatment Outcome | 2020 |
Clubbed Digits Presumably Caused by Lubiprostone.
Topics: Adult; Alprostadil; Constipation; Female; Humans; Liver; Lubiprostone; Neoplasms; Osteoarthropathy, Secondary Hypertrophic | 2021 |